Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

Completed · Phase 2

Conditions studied: IgG Deficiency, Infections

In brief

* This is the first study, that we are aware of, that will evaluate the efficacy of IgIV in patients with IgG subclass deficiency. * Will provide data for further collaboration in extending study to involve other immunological centers in the United States to study patients with similar disease.

Key facts

Study ID

NCT00417573

Run by

The Center for Rheumatic Disease, Allergy, & Immunology

People needed

10

Starts

2004-12-01

Expected to finish

2006-12-01

Last updated by the study team

2007-01-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (18 or older) with deficiency in one or more IgG subclasses with documented history of recurrent infections limited to upper or lower respiratory tract, urinary, and/or skin.

You may not qualify if…

• Patients with panhypogammaglobulinemia or selective IgA deficiency.

Where it is running

• Center for Rheumatic Disease, Allergy, Immunology — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.